Blood Coagulants Market Information, By Types (Coagulation Factor, others), By Indication (Haemophilia, Surgery, other Bleeding Disorders – Middle East & Africa Forecast till 2023

Blood Coagulants Market Information, By Types (Coagulation Factor, others), By Indication (Haemophilia, Surgery, other Bleeding Disorders – Middle East & Africa Forecast till 2023

Market analysis

Coagulation is the procedure, by which blood changes from a fluid to a gel, shaping a blood coagulation. Generally speaking, coagulation is a particular process in which the blood frames clumps to blocks and afterward mend a sore/injury/cut and pause the bleeding. In the Sub-Saharan Africa and the Middle East, bleeding issues has now become a common problem as there is a limited number of proper screening and treatment processes. Also, people living there are ignorant about this disease which is one of the major cause for the people suffering from bleeding disorder. The Middle East and Africa blood coagulant market development is significantly ascribed to expanding pervasiveness of the bleeding issue, rising subsidizing, insurance protection cover, and various awareness programs for bleeding issue. However, the lack of research and development capabilities, lack of awareness among the public and the presence of the counterfeit drugs are some of the major factors hindering the market growth. The MEA blood coagulants market is expected to grow at a CAGR of 9.5% during the forecast period 2017-2023.

Market segmentation

The MEA blood coagulants market is divided on the basis of its indications, types, and by country.
On the basis of its indication, the market is bifurcated into surgery, haemophilia, and other bleeding disorders. Based on its types, the market is classified into coagulation factor and others.

Regional analysis

Based on its country, the market is divided into UAE, KSA, Qatar, Kuwait, Oman, Egypt, and the Rest of Middle East & Africa.

Major players

Some of the major industry players in the MEA blood coagulants market includes brands like Bayer AG (Germany), Pfizer Inc. (U.S.), Novo Nordisk AS (Dernmark), SOBI (Sweden), Octapharma (Switzerland), Shire (Republic of Ireland), CSL Limited (Australia), among others.



1 Report Prologue
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Bleeding disorder and related conditions will push the demands on health systems (Impact weightage 75%)
3.2.2 Rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders are expected to boost the growth of the market (Impact weightage 25%)
3.3 Restrains
3.3.1 Lack of R&D capabilities: (Impact weightage 45%)
3.3.2 Counterfeit Drugs (Impact weightage 35%)
3.3.3 Lack of Awareness (Impact weightage 20%)
4 Middle East & Africa Blood Coagulants Market By Type
4.1 Introduction
4.2 Coagulation Factor
4.2.1 Recombinant Coagulation Factor
4.2.2 Plasma Derived Coagulation Factor
5 Middle East & Africa Blood Coagulants Market, By Indication
5.1 Introduction
5.2 Haemophilia
5.3 Surgery
5.4 Other Bleeding Disorders
6 Middle East & Africa Blood Coagulants Market, By Country
6.1 Introduction
6.2 Saudi Arabia (KSA)
6.3 United Arab Emirates (UAE)
6.4 Qatar
6.5 Oman
6.6 Kuwait
6.7 Egypt
6.8 Rest of Middle East & Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Company Overview
7.1.2 Financials
7.1.3 Products
7.1.4 Strategies
7.1.5 Key Developments
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financials
7.2.3 Products
7.2.4 Strategies
7.2.5 Key Developments
7.3 Novo Nordisk AS
7.3.1 Company Overview
7.3.2 Financials
7.3.3 Products
7.3.4 Strategies
7.3.5 Key Developments
7.4 Shire
7.4.1 Company Overview
7.4.2 Financials
7.4.3 Products
7.4.4 Strategies
7.5 SOBI
7.5.1 Company Overview
7.5.2 Financials
7.5.3 Products
7.5.4 Strategies
7.5.5 Key Developments
7.6 Octapharma
7.6.1 Company Overview
7.6.2 Financials
7.6.3 Products
7.6.4 Strategies
7.6.5 Key Developments
7.7 CSL Limited
7.7.1 Company Overview
7.7.2 Financials
7.7.3 Products
7.7.4 Strategies
7.7.5 Key Developments


List Of Tables



TABLE 1 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA RECOMBINANT COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA PLASMA DERIVED COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR HAEMOPHILIA BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR SURGERY BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR OTHER BLEEDING DISORDERS BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2014 TO 2023 (USD MILLION)
TABLE 11 SAUDI ARABIA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 12 SAUDI ARABIA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 13 SAUDI ARABIA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 14 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 15 UNITED ARAB EMIRATES COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 16 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 17 QATAR BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 18 QATAR COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 19 QATAR BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 20 OMAN BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 21 OMAN COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 22 OMAN BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 23 KUWAIT BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 24 KUWAIT COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 25 KUWAIT BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 26 EGYPT BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 27 EGYPT COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 28 EGYPT BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)
TABLE 29 REST OF MEA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 30 REST OF MEA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
TABLE 31 REST OF MEA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD MILLION)


List Of Figures



FIGURE 1 RESEARCH PROCESS OF MRFR
FIGURE 2 MIDDLE EAST & AFRICA MARKET: FORECAST MODEL
FIGURE 3 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2016 & 2023 (USD MILLION)
FIGURE 4 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2016 & 2023 (USD MILLION)
FIGURE 5 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2016 & 2023 (USD MILLION)
FIGURE 5 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION)


Blood Banking and NAT Screening Market. 2019-2023: Supplier Shares and Sales Forecasts by Country, Strategic Profiles of Leading Suppliers

This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for

USD 3500 View Report

Molecular Blood Typing, Grouping and Infectious Disease NAT Market. 2019-2023: Supplier Shares by Country, Screening Assays, and Companies Developing New Technologies and Products

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive

USD 3850 View Report

Europe Blood Coagulants Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Blood Coagulants market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the

USD 3000 View Report

Asia Pacific Blood Coagulants Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Blood Coagulants market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available